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Abstract
Introduction: Therapy-associated onset of stemness-maintenance in surviving tumor-cells dictates tumor relapse/
recurrence. Recently, we recognized the anti-pancreatic cancer (PC) potential of seaweed polyphenol manifolds
and narrowed down three superior drug-deliverables that could serve as adjuvants and benefit PC cure. Utilizing
the PC- cancer stem cells (PC-CSCs) grown ex vivo and mouse model of residual-PC, we investigated the benefits
of seaweed polyphenols in regulating stemness-maintenance.
Methods: ALDH+CD44+CD24+ PC-CSCs from Panc-1, Panc-3.27, MiaPaCa-2, or BxPC-3 cells-derived xenografts grown
ex vivo were either mock-irradiated, exposed to fractionated irradiation (FIR, 2Gy/D for 5 days), treated with polyphenols
(100 μg/ml) of Hormophysa triquerta (HT-EA), Spatoglossum asperum (SA-EA) or Padina tetrastromatica (PT-EA) with/
without FIR were examined for cell viability, transcription of 93 stem-cell-related molecules (QPCR profiling).
Polyphenol-dependent regulation of FIR-transactivated Oct4, Zic3, EIF4C, Nanog, and LIF (QPCR) and functional
translation of Nanog, SOX2, and OCT3/4 (immunoblotting) were examined in Panc-1/Panc-3.27/MiaPaCa-2/BxPC-
3-xenografts derived PC-CSCs. Effect of seaweed-polyphenols in the regulation of EMT (N-Cadherin), pluripotency-
(SOX2, OCT3/4, Nanog) and stemness-maintenance (PI3KR1, LIF, CD44) in therapy (FIR, 2Gy/D for 5D/wk for
3-weeks) resistant residual tumors were examined by tissue microarray construction and automated
immunohistochemistry.
Results: Ex vivo exposure of PC-CSCs to SA-EA, PT-EA and HT-EA exhibit dose-dependent inhibition of cell
viability. FIR amplified the transcription of 69, 80, 74 and 77 stem-cell related genes in MiaPaCa-2-, Panc-1-, Panc-
3.27- and BXPC3-established xenograft-derived ALDH+CD44+CD24+PC-CSCs. Treatment with SA-EA, PT-EA, or HT-EA
completely suppressed FIR-activated stem-cell transcriptional machinery in ALDH+CD44+CD24+PC-CSCs established
from MiaPaCa-2, Panc-1, Panc-3.27 and BXPC3 xenografts. QPCR validated EIF4C, OCT3/4, Nanog, LIF, and ZIC3
transcriptional profile outcomes. Nanog, Sox2, and OCT3/4 immunoblotting affirmed the PC-CSC radiosensitizing
benefit of seaweed polyphenols. Residual-PC tissues microarrayed and immunostained after in vivo treatments
recognized complete regulation of FIR-induced SOX2, OCT3/4, Nanog, LIF, CD44, PIK3R1, N-Cadherin, and E-Cadherin
with SA-EA, PT-EA, and HT-EA.
Conclusions: These data, for the first time, documented the EMT/stemness-maintenance in therapy-resistant PC-CSCs.
Further, the data suggest that seaweed polyphenols may inhibit PC relapse/recurrence by targeting therapy-orchestrated
stem-cell signaling in residual cells.
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Introduction
Clinical and laboratory evidence suggests that several
common human cancers contain populations of rapidly
proliferating clonogens that can have a substantial impact
on local control following chemoradiotherapy or conven-
tional radiotherapy [1]. Recurring tumors may arise from
remnant cells of the original neoplasm that have escaped
therapeutic intervention and later become visible at the
original site [2, 3]. For many cancers, it has been hypothe-
sized that tumor cells responsible for failures in long-term
remission exhibit stem cell properties [4–6]. It is now
being appreciated that tumors contain a small number of
tumor-forming and self-renewing cancer stem cells
(CSCs) within a population of nontumor-forming cancer
cells that contribute to pancreatic cancer (PC) progression
and relapse [7]. The CSC hypothesis suggests that con-
ventional chemoradiotherapy kills differentiated/differ-
entiating cells that form the bulk of the tumor, but
cannot generate new cells. Tumor relapse may occur
because CSCs remain untouched by treatment, suggest-
ing that the removal of CSCs is crucial for effective
therapy. In addition, recent evidence points to the ex-
istence of programmed functional plasticity not only in
CSCs, but also in nonstem cancer cell populations [8, 9].
Detailed pathological analysis of PC has confirmed genet-
ically traceable unique subclone association with meta-
static lesions [10, 11], and further suggests that multiple
genetic subclones are constantly evolving, competing in
parallel within the primary tumor, and might independ-
ently give rise to metastatic lesions. In addition, recent
genetic profiles of CSCs [12] demonstrated genetically di-
verse tumor-initiating cells in genetically-driven tumors.
As CSCs have been shown to be more resistant to che-
moradiation than the rest of the tumor cell population
[13–16], this selective pressure would automatically se-
lect the genetic clones that contain a higher proportion
of CSCs, and thereby have greater potential for recon-
stituting tumor growth once the therapeutic regimen is
finished. In this regard, delineating the contribution of
reactivated (after first-line therapy) developmental sig-
naling pathways to PC initiation and progression [17]
would shed light on understanding the CSCs’ role in
PC progression and relapse.
Early forays into CSC-targeted therapies in combination
with standard therapies [18, 19] have shown that some
combinations have efficacy against PC-CSCs [20, 21],
decreased tumorosphere-forming capacity, and in vivo
tumorigenicity. These approaches reveal the possibility of
developing CSC-targeted therapies that could potentially
be used alongside chemotherapy and radiation to specific-
ally eliminate CSC subpopulations and reduce tumor re-
currence. Seaweeds rich in polyphenols [22] have been
shown to exert anti-tumor [23] potential, particularly in
inhibiting cell proliferation [24], tumor regression [25],
and inhibition of metastasis [26]. A close association
between polyphenols’ anti-carcinogenic activity and
antioxidant activity has been reported in mouse models
of carcinoma [25, 27]. Recent investigations demonstrated
the anti-proliferative, pro-apoptotic, DNA-damaging, anti-
angiogenic, growth-inhibiting, cell-cycle arrest, and anti-
metastatic functions of seaweed extracts in various tumor
models [28–31]. We have recently demonstrated that po-
larity-based polyphenol fractions extracted from brown
algae exerted potent anti-PC potentials in vitro, and
further identified three high-polarity fractions that
could be clinically translatable [32]. This study defined
the therapy-associated stem cell-related molecular sig-
nature in residual ALDH+CD44+CD24+ PC-CSCs, and




Genetically diverse human Panc-1, MiaPaCa-2, Panc-
3.27, and BxPC-3 cells were cultured and maintained as
described earlier [32, 33].
Xenotransplantation mouse model
All experiments conformed to American Physiological
Society standards for Animal Care, were carried out in ac-
cordance with the guidelines laid down by the National
Research Council, and were approved by the University of
Oklahoma Health Sciences Center Institutional Animal
Care and Use Committee. Seven-week-old male athymic
NCr-nu/nu nude mice weighing 25–30 g were acclima-
tized for at least 3 days before the study. We administered
5 × 106 Panc-1, Panc-3.27, MiaPaCa-2, or BxPC-3 cells
(with 30 % Matrigel; Corning, Tewksbury, MA, USA)
subcutaneously into their right flanks. Tumor growth was
periodically monitored and was allowed to grow to a
volume of at least 100 mm3.
Isolation of PC-CSCs
PC-CSCs from Panc-1, Panc-3.27, MiaPaCa-2, or BxPC-3
cell-derived xenografts were isolated by flow cytometry
[34]. Briefly, dissociated cells were pelleted, resuspended in
ALDEFLUOR buffer, and sorted by defining their pheno-
types with parallel controls. We adopted the sequential
exclusion→ inclusion criteria to isolate human ALDH+
CD44+CD24+ PC-CSCs from the xenograft. Cells were





CSCs were screened based on CD24+CD44+ALDH+ subtypes
(Fig. 1a). ALDH+CD44+CD24+ PC-CSCs characterized and
isolated from the xenografts established using MiaPaCa-2,
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Panc-1, Panc-3.27, and BXPC-3 were discretely collected
and maintained ex vivo in stem cell medium (cell-line
specific basal-medium without fetal bovine serum (FBS),
complemented with 40 ng/ml epidermal growth factor
(EGF), 10 ng/ml fibroblast growth factor (FGF), B27, N2
supplements). All sorted ALDH+CD44+CD24+ PC-CSCs
exhibited tumorosphere formation under serum-free con-
trolled conditions ex vivo (Figure S1A in Additional file 1).
In vitro and in vivo irradiation procedures
ALDH+CD44+CD24+ PC-CSCs grown ex vivo were either
mock irradiated or exposed to fractionated irradiation (FIR,
Fig. 1 a Flow cytometry plots showing populations from human PC xenografts. PI+, mouse-CD31+mouse-lineage+, or mouse-H-2Kd+ cells are
excluded in order to isolate only viable nonmouse-derived cells. ALDH activity was measured using ALDEFLUOR reagent (Aldefluor Kit, Stem Cell
Technologies, Vancouver, BC, Canada) in the presence/absence of N,N-diethylaminobenzaldehyde (DEAB) . The CD44+CD24+ gate was created
based on cells stained with ALDEFLUOR, and IgG2bk-APC (isotypic control) and IgG2ak-PE (isotypic control) antibodies. Percentage of ALDH+CD44+CD24+
cells is given in the text. b Line plots showing cell-viability dose–response curves of PC-CSCs exposed to seaweed polyphenols. PC-CSCs derived
from xenografts established using MiaPACa-2, Panc-1, Panc-3.27, or BXPC-3 cells were exposed to increasing concentrations (10, 20, 50, or 100 μg/ml) of
SA-EA, PT-EA, or HT-EA and examined for alterations in cell viability using the automated countess trypan blue exclusion assay. Treatment with seaweed
polyphenols exhibited dose-dependent inhibition of PC-CSC cell viability with maximum inhibition at 100 μg/ml. The dose-dependent decrease in cell
viability by SA-EA, HT-EA, and PT-EA remained consistent in all four PC-CSC clones investigated. ALDH aldehyde dehydrogenase, CSC cancer stem cell,
HT-EA ethyl acetate polyphenol fraction of Hormophysa triquerta, PC pancreatic cancer, PT-EA ethyl acetate polyphenol fraction of Padina tetrastromatica,
SA-EA ethyl acetate polyphenol fraction of Spatoglossum asperum
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2 Gy/D for 5 days) using a Gamma Cell 40 Exactor (Best
Theratronics, Ottawa, ON, Canada) at a dose rate of
0.81 Gy/minute. In vivo PC xenografts were selectively ex-
posed to FIR (2 Gy/day for 5 days per week for 3 weeks)
to a total dose of 30 Gy. A specially designed cerrobend
shield was used to encase the bodies of the mice, exposing
only the flank tumors, as described earlier [35–37]. Dos-
imetry was measured using both thermoluminescent and
radiochromic film dosimetry [35]. Mock-irradiated ani-
mals were treated identically, except that they were not
subjected to radiation.
Polyphenol treatments
Polarity-based extractions of seaweed polyphenols were
performed as described earlier [32]. For this study, ethyl
acetate fractions of Hormophysa triquerta (HT-EA),
Spatoglossum asperum (SA-EA), and Padina tetrastro-
matica (PT-EA) were selectively examined. Seaweeds are
collected as a part of the Department of Science and
Technology, Government of India-sponsored DBT pro-
ject and, since this collection does not involve any en-
dangered or protected species, no specific permissions
were required (Forest Department, Government of India
exempt). In brief, freshly collected, oven-dried, and pow-
dered algae (50 g) was subjected to sequential extraction
in gradient (increasing) polarity solvents including hex-
ane, dichloromethane, ethyl acetate, and methanol for
48 h each at room temperature. The slurry in each phase
was filtered and the residue was subjected for extraction
in the subsequent solvent. The dried filtrates were
weighed and dissolved in dimethyl sulfoxide (DMSO) to
a stock concentration of 100 mg/ml. For cell treatment,
stock solutions were diluted in plain cell culture medium
to a “working” concentration of 10 mg/ml. For all ex
vivo investigations, ALDH+CD44+CD24+ PC-CSCs
were treated with 100 μg/ml of each polyphenol frac-
tion, while a corroborated 10 mg/kg concentration was
used for in vivo studies. The final concentration of
DMSO in the cell culture medium was 0.0001 %.
Cell viability
The trypan blue exclusion assay utilizing an automated
countess was used to identify the efficacy of polyphenols
in the regulation of PC-CSC cell viability. ALDH+CD44
+CD24+ PC-CSCs (derived from xenografts established
using MiaPaCa-2, Panc-1, Panc-3.27, and BxPC-3 cells)
grown ex vivo were treated with 10, 20, 50, or 100 μg/ml
SA-EA, PT-EA, or HT-EA, and were examined after 18 h
for alterations in cell viability, as described earlier [33].
Stem cell-related transcriptome profiling
Total RNA extraction and real-time quantitative PCR
(QPCR) profiling were performed as described earlier
[38, 39]. We used custom-made transcriptome profilers
[40] pertaining to stemness and epithelial-to-mesenchymal
transition (EMT) signaling.
QPCR
Total RNA extraction and individual gene QPCR were
performed as described earlier [41, 42]. For this study,
transcriptional alterations of Oct4, Zic3, EIF4C, Nanog,
and LIF were investigated in polyphenol-treated ALDH
+CD44+CD24+ PC-CSCs (derived from MiaPaCa-2 and
Panc-1 xenografts) exposed to FIR.
Immunoblotting
We analyzed ALDH+CD44+CD24+ PC-CSCs (derived
from MiaPaCa-2, Panc-1, Panc-3.27, and BXPC-3 xeno-
grafts) grown ex vivo and exposed to SA-EA, PT-EA, or
HT-EA fractions for the alterations in Nanog, Sox2, and
Oct3/4 after 24 h. Total protein extraction and immuno-
blotting were performed as described earlier [43].
Tissue microarray construction and
immunohistochemistry/immunofluorescence
All tissue microarray (TMA) construction procedures
were performed in the SCC Cancer Tissue Pathology
Core. We examined the cellular localization and expression
of N-Cadherin, OCT3/4, Sox2, LIF, PI3KR1, CD44,
and Nanog. Appropriate tissue morphologic/pathologic
(hematoxylin and eosin (H&E)) controls and negative (no
primary antibody) controls were examined in parallel. The
slides were microdigitally scanned using a Scanscope and
analyzed using Aperio Integrated Spectrum software (Leica
Biosystems Inc., Buffalo Grove, IL, USA). For E-Cadherin,
the primary protein is tagged with Mix-n-Stain™ CF™ 488A
Antibody Labeling Kit (Sigma, St. Louis, MO), while the
cell membrane was marked with wheat germ agglutinin
(WGA)–Alexaflour-594 (LifeTechnologiesCorporation,Grand
Island, NY, USA) and nuclear counterstained with 4′,6-
diamidino-2-phenylindole (DAPI). Immunofluorescence
was measured in Operetta and analyzed with Columbus
image data analysis.
Oxidative stress assay
A rapid and sensitive luminescent H2O2 assay (ROS-Glo™
H2O2 Assay; Promega, Madison, WI, USA) was used to
identify the efficacy of polyphenols in the regulation of
PC-CSC oxidative stress. In brief, ALDH+CD44+CD24+
PC-CSCs (derived from MiaPaCa-2 xenograft) grown ex
vivo were treated with 100 μg/ml SA-EA, PT-EA, or HT-
EA and were allowed to incubate for 18 h. The cells were
then incubated with H2O2 (25 μM final concentration)
substrate solution for an additional 6 h (37 °C, 5 % CO2).
The H2O2-proportional generated luciferin precursor was
then converted to luciferin with L-cysteine and allowed to
react (20 min in the dark) with Ultra Glo™ recombinant lucif-
erase, and the luminescence was quantified using a Synergy
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2 multimode reader (BioTek Instruments Inc., Winooski,
VT, USA). Since polyphenols undergo abiotic reaction in cell
culture medium and produce H2O2 [44, 45], appropriate “no
medium”, “medium”, “medium+drug”, and “medium+ cell”
controls are included. All experiments were repeated three
times and the background (no cells control) media factor
normalized luminescence was compared between the groups
using analysis of variance (ANOVA) with Bonferroni’s post-
hoc comparison (GraphPad PRISM, La Jolla, CA, USA).
Results
Seaweed polyphenols inhibit PC-CSCs’ cell viability ex vivo
We analyzed MiaPaCa-2, Panc-1, Panc-3.27, and BxPC-3
cell-associated xenograft-derived PC-CSCs exposed to
varying concentrations of SA-EA, PT-EA, or HT-EA for
alterations in cell viability. PC-CSCs exposed to SA-EA,
PT-EA, or HT-EA showed consistent inhibition of viabil-
ity in concentrations as low as 10 μg/ml (Fig. 1b) in all
four PC-CSC clones investigated. We observed a robust
and dose-dependent inhibition of cell viability with in-
creasing concentrations of SA-EA, PT-EA, or HT-EA with
a maximum inhibition at 100 μg/ml. Panc-1-derived PC-
CSCs were relatively very sensitive and demonstrated a
linear dose-dependent inhibition of viability with the poly-
phenol treatment. All three polyphenols exerted a similar
effect in this CSC clone. Other interesting observations in-
clude the following: while PT-EA exerted maximum effect
in MiaPACa-2 (~40 %), Panc-1 (>60 %), and Panc-3.27
(>40 %) PC-CSCs, it exhibited relatively poor performance
in Panc-3.27 PC-CSCs (>20 %); and SA-EA exerted max-
imum efficiency against BxPC-3 PC-CSCs (~60 %) at a
concentration as low as 20 μg/ml and did not show any
further increase in activity with increasing concentrations
(Fig. 1b). Together, these results demonstrate that the sea-
weed polyphenols inflict a profound inhibition on PC-
CSC cell viability.
Seaweed polyphenols regulate the oxidative stress status
of PC-CSCs
To investigate whether the exposure of seaweed polyphe-
nols alters the oxidative stress status of the PC-CSCs,
MiaPaCa-2 xenograft-derived PC-CSCs maintained ex vivo
were exposed to 100 μg/ml SA-EA, PT-EA, or HT-EA and
analyzed for alterations in cell-generated H2O2 utilizing the
Promega cell-based ROS-Glo™ H2O2 Assay. Since polyphe-
nols undergo abiotic reaction in cell culture medium and
produce H2O2 [44, 45], appropriate in-house controls (no
medium, medium, medium + drug, and medium+ cell con-
trols) are included. Compared with the untreated controls,
all three polyphenols investigated exhibited a significant
(P <0.001) regulation of oxidative stress in PC-CSCs (Figure
S1B in Additional file 1). Relatively we observed a robust
effect with SA-EA in the regulation of oxidative stress in
PC-CSCs.
Therapy actuates stem cell-related transcriptome in PC-
CSCs
To characterize the heightened stemness of PC-CSCs that
survive radiotherapy, we examined the modulations in 93
stem cell-related molecules in ALDH+CD44+CD24+ PC-
CSCs that were derived from the xenografts established
using genetically diverse MiaPaCa-2, Panc-1, Panc-3.27,
and BXPC-3 cells. PC-CSCs maintained ex vivo were ex-
posed to clinically relevant FIR. The FIR resulted in the
robust (≥2-fold) activation of 69, 80, 74, and 77 stem cell-
related molecules in PC-CSCs of MiaPaCa-2, Panc-1,
Panc-3.27, and BXPC-3 origin respectively (Additional file
2). Interestingly, 43 genes (ABCG2, ACAN, ADAR,
ALDH1A1, ALDH2, ALPI, APC, ASCL2, AXIN1, BGLAP,
BMP3, CD4, CD8A, CDC42, CDH1, COL2A1, COL9A1,
CTNNA1, DTX1, DTX2, DVL1, FGFR1, GDF3, GJB1,
GJB2, HDAC2, HRAS, ISL1, JAG1, MSX1, MYOD1,
NOTCH2, NUMB, OCLN, PPARD, S100B, SHH, SNAI1,
SNAI2, TBX2, TERT, TUBB3, TWIST1) showed robust cell
line-independent upregulation (Additional file 2). Further,
cell lines to genes traverse analysis identified an additional
34 genes showing cell line-independent upregulation in
three cell lines, and another 11 genes showing such upreg-
ulation in two cell lines. Distinctively, GSK3B in MiaPaCa-
2-derived PC-CSCs and NCAM1 in Panc-3.27-derived
PC-CSCs showed cell line-dependent activation. Together,
these data demonstrate the activation of stem cell-related
molecules in PC-CSCs that survive radiation.
Seaweed polyphenols target therapy-activated stem cell-
related transcription in PC-CSCs
Next, we examined the transcriptional modulation of stem
cell-related molecules in ALDH+CD44+CD24+ PC-CSCs
pretreated with SA-EA, PT-EA, and HT-EA, and exposed
to FIR. SA-EA significantly inhibited 60 (of 80), 30 (of 74),
65 (of 77), and 59 (of 69) FIR-induced (≥2-fold) stem cell-
related molecules in Panc-1, MiaPaCa-2, Panc-3.27, and
BXPC-3-derived PC-CSCs respectively. While 11 of the
43 cell line-independent FIR-induced genes (APC, CD8A,
CDH1, COL9A1, CTNNA1, DVL1, GJB1, GJB2, ISL1,
OCLN, TBX2) were completely suppressed by SA-EA
treatment across all four PC-CSC clones investigated
(Fig. 2‡), we also observed a cell line-independent inhib-
ition of 15 genes (ALDH1A1, ASCL2, AXIN1, BGLAP,
CD4, DTX2, FGFR1, HDAC2, HRAS, JAG1, MSX1,
PPARD, SNAI1, SNAI2, TUBB3) in at least three PC-CSC
clones (Fig. 2†) and 16 other genes (ABCG2, ACAN,
ADAR, ALDH2, ALPI, BMP3, CDC42, COL2A1, DTX1,
GDF3, MYOD1, NOTCH2, NUMB, SHH, TERT, TWIST1)
in two PC-CSC clones (Fig. 2*). However, cell line-
dependent inhibition of S100β in PC-CSCs of BXPC-3
origin with SA-EA was also observed. Likewise, PT-EA
treatment completely inhibited 46, 37, 43, and 65 of 80,
74, 77, and 69 FIR-induced stem cell-related molecules in
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Panc-1, MiaPaCa-2, Panc-3.27, and BXPC-3-derived
PC-CSCs. However, of 43 cell line-independent FIR-
induced genes, the comparison analysis revealed a cell
line-independent inhibition of 10 genes (ALDH2, APC,
AXIN1, DVL1, FGFR1, GJB2, HRAS, ISL1, TBX2, TUBB3)
in all four PC-CSC clones (Fig. 3‡). In addition, a set of 17
genes (ABCG2, ADAR, ALPI, ASCL2, BGLAP, CD4, CD8A,
COL9A1, CTNNA1, DTX1, DTX2, MSX1, MYOD1, OCLN,
PPARD, SNAI1, TWIST1) inhibited in common in at least
three PC-CSC clones (Fig. 3†), while another 11 genes
(ALDH1A1, BMP3, CDC42, COL2A1, GDF3, GJB1,
HDAC2, JAG1, NUMB, SNAI2, TERT) were completely
inhibited in two PC-CSCs with PT-EA (Fig. 3*). However,
PT-EA silenced a small subset of genes (ACAN, S100β,
SHH in BXPC-3; CDH1 in MiaPaCa-2; NOTCH2 in Panc-
1 PC-CSC) in a cell line-dependent manner. Pretreating
Fig. 2 Vertical stacked bars from QPCR profiling showing the regulation of FIR-amplified stem cell-related transcription with SA-EA treatment in
ALDH+CD44+CD24+ PC-CSCs derived from xenografts established using MiaPaCa-2, Panc-1, Panc-3.27, and BXPC-3. Inhibitory potential of SA-EA
was compared for the 43 genes that showed cell line-independent increase after fractionated radiation across all four PC-CSC clones investigated.
Cell line-independent effect of SA-EA for any given gene is indicated with “‡” for four, with “†” for three, and with “*” for two PC-CSC clones; “Δ”
for cell line-dependent effect. In the stacked bar, SA-EA + FIR bars are overlaid on top of the FIR bars and the y axis is restricted to a maximum of
20-fold for better presentation of comparative display. Overall, SA-EA treatment exerted cell line-independent inhibition of 11 of the 43 FIR-induced
genes (APC, CD8A, CDH1, COL9A1, CTNNA1, DVL1, GJB1, GJB2, ISL1, OCLN, TBX2). CSC cancer stem cell, FIR fractionated irradiation, PC pancreatic cancer,
SA-EA ethyl acetate polyphenol fraction of Spatoglossum asperum
Aravindan et al. Stem Cell Research & Therapy  (2015) 6:182 Page 6 of 14
cells with HT-EA inhibited 80 (of 80), 72 (of 74), 75 (of
77), and 23 (of 69) FIR-induced stem cell-related mole-
cules in Panc-1, MiaPaCa-2, Panc-3.27, and BXPC-3-
derived ALDH+CD44+CD24+ PC-CSCs. Interestingly, 14
of 43 FIR-induced genes (ALDH1A1, ALPI, APC, AXIN1,
BGLAP, CD4, CDC42, CTNNA1, GJB1, HDAC2, HRAS,
JAG1, SHH, TBX2) were completely suppressed with HT-
EA treatment in all four PC-CSCs investigated (Fig. 4‡).
We observed a significant cell line-independent inhibition
of 29 (ABCG2, ACAN, ADAR, ALDH2, ASCL2, BMP3,
CD8A, CDH1, COL2A1, COL9A1, DTX1, DTX2, DVL1,
FGFR1, GDF3, GJB2, ISL1, MSX1, MYOD1, NOTCH2,
NUMB, OCLN, PPARD, S100B, SNAI1, SNAI2, TERT,
TUBB3, TWIST1) in three PC-CSCs with HT-EA treat-
ment (Fig. 4†). Evidently, FIR-induced APC and TBX2
were completely and consistently inhibited by all three
seaweed polyphenols tested in all four PC-CSC clones in-
vestigated. Together, these data demonstrate the selective
FIR-induced stem cell-related transcriptome inhibitory
potential of SA-EA, PT-EA, and HT-EA in PC-CSCs that
survive radiotherapy.
Seaweed polyphenols target radiotherapy-activated
EIF4C, OCT3/4, Nanog, LIF, and ZIC3 in PC-CSCs
To further recognize the regulation potential of seaweed
polyphenols in the stem cell-related transcriptional ma-
chinery that drives EMT, pluripotency maintenance, and
the self-renewal capacity of PC-CSCs, we examined the
transcriptional modulations of EIF4C, OCT3/4, Nanog,
LIF, and ZIC3 in PC-CSCs. SOX2, OCT3/4, Nanog, LIF,
EIF4C, and ZIC3 comprise the core regulatory circuitry
in stem cells that overturns differentiation-associated
genes, and determines the improved stemness, pluripo-
tency maintenance, and self-renewal capacity. Since
these critical players (except for Sox2) are not included
in the QPCR profiling, we investigated whether radiation
Fig. 3 Vertical stacked bars from QPCR profiling showing the regulation of FIR-amplified stem cell-related transcription with PT-EA treatment in
ALDH+CD44+CD24+ PC-CSCs derived from xenografts established using MiaPaCa-2, Panc-1, Panc-3.27, and BXPC-3. Inhibitory potential of PT-EA
was compared for the 43 genes that showed cell line-independent increase after fractionated radiation across all four PC-CSC clones investigated.
Cell line-independent effect of PT-EA for any given gene is indicated with “‡” for four, with “†” for three, and with “*” for two PC-CSC clones; “Δ”
for cell line-dependent effect. In the stacked bar, PT-EA + FIR bars are overlaid on top of the FIR bars and the y axis is restricted to a maximum of
20-fold for better presentation of comparative display. Overall, PT-EA treatment exerted cell line-independent inhibition of 10 of the 43 FIR-
induced genes (ALDH2, APC, AXIN1, DVL1, FGFR1, GJB2, HRAS, ISL1, TBX2, TUBB3). CSC cancer stem cell, FIR fractionated irradiation, PC pancreatic can-
cer, PA-EA ethyl acetate polyphenol fraction of Padina tetrastromatica
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activates these stemness-maintenance markers in PC-
CSCs and further defined the benefit of seaweed poly-
phenols in mitigating such transcriptional/translational
response. First, we examined the benefit of seaweed
polyphenols in targeting EIF4C, OCT3/4, Nanog, LIF,
and ZIC3 transcriptional activation as a standalone drug.
For this, ex vivo maintained PC-CSCs (derived using
MiaPaCa-2 and Panc-1 cells) were exposed to 100 μg/ml
SA-EA, PT-EA, or HT-EA and examined after 24 h.
Overall, SA-EA, PT-EA, or HT-EA treatment exhibited
a significant and consistent transcriptional inhibition of
EIF4C, OCT3/4, Nanog, LIF, and ZIC3 in both MiaPaCa-2
and Panc-1-derived PC-CSCs (Figure S1C in Additional
file 1). Evidently, SA-EA and PT-EA treatment exerted
significant inhibition of OCT3/4, Nanog, and LIF in both
PC-CSCs investigated. On the other hand, exposing the
cells to HT-EA resulted in the complete inhibition of
OCT3/4 in both PC-CSCs. Next, we examined the
transcriptional modulation of EIF4C, OCT3/4, Nanog, LIF,
and ZIC3 in MiaPaCa-2 and Panc-1-derived ALDH+CD44
+CD24+ PC-CSCs pretreated with SA-EA, PT-EA, and
HT-EA, and exposed to radiotherapy. Therapy-associated
activation of EIF4C in both PC-CSC clones was signifi-
cantly inhibited in the presence of SA-EA, PT-EA, and
HT-EA (Fig. 5a). Consistently, all three fractions inflict cell
line-independent inhibition of FIR-induced OCT3/4 tran-
scription in PC-CSCs (Fig. 5a). Moreover, we observed
significant inhibition of Nanog transactivation in both PC-
CSCs with SA-EA, PT-EA, and HT-EA (Fig. 5a). Further,
QPCR analysis recognized the definite inhibition of
radiotherapy-induced LIF transactivation in PC-CSCs in
the presence of seaweed polyphenols (Fig. 5a). Zic3 that
was significantly activated in response to therapy was
completely suppressed in PC-CSCs with SA-EA, PT-EA,
or HT-EA (Fig. 5a). Immunoblotting revealed that the
SA-EA, PT-EA, or HT-EA profoundly regulate therapy-
Fig. 4 Vertical stacked bars from QPCR profiling showing the regulation of FIR-amplified stem cell-related transcription with HT-EA treatment in
ALDH+CD44+CD24+ PC-CSCs derived from xenografts established using MiaPaCa-2, Panc-1, Panc-3.27, and BXPC-3. Inhibitory potential of HT-EA
was compared for the 43 genes that showed cell line-independent increase after fractionated radiation across all four PC-CSC clones investigated.
Cell line-independent effect of HT-EA for any given gene is indicated with “‡” for four, with “†” for three, and with “*” for two PC-CSC clones; “Δ”
for cell line-dependent effect. In the stacked bar, PT-EA + FIR bars are overlaid on top of the FIR bars and the y axis is restricted to a maximum of
20-fold for better presentation of comparative display. Overall, HT-EA treatment exerted cell line-independent inhibition of 14 of the 43 FIR-induced
genes (ALDH1A1, ALPI, APC, AXIN1, BGLAP, CD4, CDC42, CTNNA1, GJB1, HDAC2, HRAS, JAG1, SHH, TBX2). CSC cancer stem cell, FIR fractionated irradiation,
HT-EA ethyl acetate polyphenol fraction of Hormophysa triquerta, PC pancreatic cancer
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induced expression of pluripotency, maintaining Nanog,
SOX2, and OCT3/4 in MiaPaCa-2, Panc-1, Panc-3.27, and
BXPC-3-derived ALDH+CD44+CD24+ PC-CSCs (Fig. 5b).
Band intensity densitometry results corroborated well
with the transcription data and recognized the potential of
these drug deliverables in stemness-related functional
response (Fig. 5c).
Seaweed polyphenols regulate SOX2, PI3KR1, OCT3/4,
N-Cadherin, E-Cadherin, Nanog, LIF, and CD44 in residual
PC in vivo
To further substantiate our ex vivo findings, we exam-
ined the cellular expression/localization levels of SOX2,
PI3KR1, OCT3/4, N-Cadherin, E-Cadherin, Nanog, LIF,
and CD44 in residual PC. SOX2 staining revealed basal
levels (0.31 ± 0.13 %) of positivity in mock-irradiated xeno-
grafts (Fig. 6). The positivity of SOX2 appeared in dark
brown, and was principally localized in the nucleus (pull-
out in Additional file 3). SOX2 immunoreactivity was
intense (14.35 ± 3.68 %) in residual tumors after FIR (Fig. 6;
Additional file 3). We observed a complete loss of FIR-
induced SOX2 with SA-EA, PT-EA, or HT-EA (Fig. 6b).
Expression of PIK3R1 was stronger in tumor cells than
in stromal cells, and was predominantly localized in
plasma membranes as well as in the cytoplasm (pullout
in Additional file 4). Radiotherapy-treated xenografts
Fig. 5 a QPCR analysis showing mRNA levels of EIF4C, OCT3/4, Nanog, LIF, and ZIC3 in ALDH+CD44+CD24+ PC-CSCs derived from xenografts of
Panc-1 and MiaPaCa-2, either mock irradiated or exposed to FIR, with or without 100 μg/ml SA-EA, PT-EA, or HT-EA. b Representative immunoblots
showing expression levels of Nanog, Sox2, and Oct3/4 in Panc-1, MiaPaCa-2, Panc-3.27, and BXPC-3-derived ALDH+CD44+CD24+ PC-CSCs, either mock
irradiated or exposed to radiation, with or without SA-EA, PT-EA, or HT-EA. c Histograms show the Quantity-One densitometry of relative band
intensities. ALDH aldehyde dehydrogenase, ANOVA analysis of variance, CSC cancer stem cell, FIR fractionated irradiation, HT-EA ethyl acetate polyphenol
fraction of Hormophysa triquerta, PC pancreatic cancer, PT-EA ethyl acetate polyphenol fraction of Padina tetrastromatica, SA-EA ethyl acetate polyphenol
fraction of Spatoglossum asperum
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demonstrated strong (49.98 ± 2.38 %) PIK3R1 expression
(Fig. 6b; Additional file 4). Although SA-EA and PT-EA
showed low levels of PIK3R1 compared with the FIR
group, PIK3R1 was barely detectable with HT-EA treat-
ment. OCT3/4-stained nuclei appeared in dark brown and
were found mainly in epithelial cells (pullout in Additional
file 5). OCT3/4 positivity ranged from 24.36 ± 3.7 % in
mock-irradiated cells to 93.29 ± 1.96 % of irradiated re-
sidual tumors (Fig. 6b; Additional file 5). The range for
OCT3/4-positive epithelial cells was 16–38 % (SA-EA),
<30 % (PT-EA), and 31.55 ± 5.85 % (HT-EA) with seaweed
polyphenol treatment.
Positive staining of N-Cadherin appeared in dark brown
and was predominantly localized in cell membranes (pull-
out in Additional file 6). Compared with mock-IR, N-
Cadherin immunoreactivity was intense in residual tumors
after FIR (Fig. 6b; Additional file 6). We observed a signifi-
cant (P <0.001) reduction in N-Cadherin immunoreactiv-
ity in the tumors of mice that received SA-EA, PT-EA,
and HT-EA. Likewise, radiotherapy exerted intense Nanog
immunoreactivity that was predominantly localized in the
nucleus (pullout in Additional file 7). SA-EA, PT-EA, and
HT-EA pretreatment showed weak nuclear Nanog (Fig. 6b;
Additional file 7). LIF-positive staining appeared in brown,
and was localized in plasma membranes, the cytoplasm,
and nuclei (pullout in Additional file 8). However,
radiotherapy-treated cells exhibited high LIF immuno-
reactivity. Regulation of the radiotherapy-induced LIF
was evident in PC tissues of animals that received SA-EA,
PT-EA, and HT-EA (Fig. 6b; Additional file 8). CD44
immunoreactivity was highly intense and present in
>50 % of the PC cells in residual tumors after FIR
(Fig. 6b). The positivity of CD44 appeared in dark
brown, and was predominantly localized in plasma
membranes and the cytoplasm (pullout in Additional
file 9 for granular cytoplasmic expression). Conversely,
SA-EA, PT-EA, and HT-EA treatment exerted signifi-
cant regulation of FIR-induced CD44 in residual PC
tumors (Additional file 9). We observed a strong E-
Cadherin immunoreactivity in mock-irradiated tumors.
The positivity of E-Cadherin appeared in green, and was
predominantly localized in plasma membranes and the
cytoplasm (pullout in Additional file 10). Immunofluor-
escence was barely detectable (<20 %) in the PC cells in
residual tumors after clinical doses of FIR (Additional
file 10). Interestingly, treatment with SA-EA, PT-EA, and
HT-EA following radiotherapy resulted on a profound in-
crease in E-Cadherin localization in residual PC tumors.
Discussion
The results of this study demonstrated the survival and
transcriptional activation of stem cell-related molecules
in ALDH+CD44+CD24+ PC-CSCs after first-line ther-
apy. For the first time, the results presented here de-
fined the clinical potential of seaweed polyphenols in
definite, comprehensive inhibition of stemness-related
molecular turmoil in PC-CSCs surviving after therapy.
Considering the magnitude of acquired (or via clonal
Fig. 6 a TMAs labeled for SOX2, PIK3R1, CD44, Nanog, LIF, OCT3/4, and N-Cadherin. b Aperio-TMA quantitation analysis showing protein-specific
positivity magnitudes in mock-irradiated xenografts and residual PC tissues after radiotherapy, with or without SA-EA, PT-EA, or HT-EA. ANOVA analysis
of variance, FIR fractionated irradiation, HT-EA ethyl acetate polyphenol fraction of Hormophysa triquerta, PT-EA ethyl acetate polyphenol fraction of
Padina tetrastromatica, SA-EA ethyl acetate polyphenol fraction of Spatoglossum asperum
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selection) EMT/CSC physiognomies in PC cells that
survive a course of therapy, the current study provides
a molecular blueprint to underscore the importance of
CSC targeting for a better PC cure. Although a number
of studies have focused on identifying the role of PC-
CSCs in drug resistance [46, 47], the selection of CSC
clones and/or acquired EMT-CSC phenotypes in response
to therapy and their functional roles in PC relapse (or for
that matter in any tumors) are poorly understood. To our
knowledge, this study was the first of its kind portraying
the amplified EMT/CSC-related molecular physiognomies
after first-line therapy in PC. Moreover, this study employs
both an in vivo preclinical approach and an ex vivo bench
approach, and demonstrates the intensified stemness in
the cells surviving after therapy. The results exposed
highly comparable activation of stemness machinery be-
tween every PC-CSC clone, depicting a similar therapy-
associated acquisition and/or enrichment of EMT/stem
characteristics, regardless of the cell of origin.
Seaweed polyphenol (SA-EA, PT-EA, or HT-EA) treat-
ment exerted a complete suppression of therapy-induced
Nanog, Oct-4, and Sox-2 in PC-CSCs. These pluripotent
CSCs maintaining Nanog, Oct-4, and Sox-2 exhibit tight
interaction and regulate their own promoters, and along
with other key developmental genes comprehensively
form autoregulatory loops and functional signaling [48].
We observed significantly high levels of Nanog in
therapy-resistant PC-CSCs ex vivo as well as in residual
PC. Evidently, a high level of Nanog is a key regulator of
stem cell self-renewal, pluripotency, and clonal expan-
sion [49, 50] and it has been shown that Nanog-deficient
cells lose their pluripotency [49]. Voluminous evidence
implicates Nanog, Sox2, and OCT-4 in the stemness and
pathogenesis of PC [51–53]. In the present study, the in-
hibition of therapy activated Nanog, SOX2, and OCT-4
by the seaweed polyphenol treatment, suggesting that
comprehensive inhibition of these self-orchestrating
CSC pluripotency maintaining factors could be a novel
strategy to prevent stemness-maintenance in therapy-
resistant PC-CSCs.
In addition, the results of the present study portray for
the first time the significant inhibition of therapy-
orchestrated N-Cadherin by the seaweed polyphenols.
EMT, an event in which epithelial cells drop their charac-
teristics and gain mesenchymal features, plays a crucial
role in tumor progression. To that end, tumor metastasis
requires the dissemination of CSCs from the primary site
and subsequently colonizes in a distant site. In this regard,
EMT has been shown to actively instigate stromal inva-
sion, intravasation, dissemination, and colonization at dis-
tant sites, all crucial and mandatory events of metastasis.
Notably, studies have shown that EMT predicts prognosis
and contributes to the drug resistance in PC [54, 55], and
a number of EMT markers are recognized in PC [56].
Consistently, results of our study show a robust increase
in the cellular levels of N-Cadherin in residual PC after
clinical doses of radiotherapy. Since its first implication
for EMT in PC [57], several studies documented its im-
portance and signaling in PC progression, and focused on
identifying drug deliverables against N-Cadherin [58–60].
However, thus far drug deliverables targeting EMT of
drug/therapy resistant cells are still unexplored. To our
knowledge, for the first time, the results of the present
study demonstrate that the seaweed polyphenols inhibit
the expression of N-Cadherin in therapy-resistant residual
tumors and further imply that these fractions could effect-
ively target EMT-driven drug/therapy resistance in PC.
CSCs have been shown to play critical roles in drug re-
sistance and tumor metastasis in many human malig-
nancies including PC. It is now evident that PC-CSCs
are resistant to well-defined chemotherapy and radio-
therapy, and contribute to PC metastasis and recurrence
after treatment by regenerating multiple cell types in the
tumor through their maintained stemness. Since it is
clear that the therapeutic failure/recurrence is due to
ineffective targeting of the PC-CSC population, drug
deliverables that selectively target PC-CSCs offer a
greater promise for PC cure as well as prevention of re-
currence. In this regard, the results of the present study
defined the stemness-related molecular blue print in
therapy-resistant PC-CSCs derived from primary tumors
established with genetically diverse human PC cells.
Moreover, this study identified the preclinical efficacy of
seaweed polyphenols in targeting PC-CSC viability and
therapy-associated activation of PC-CSC pluripotency and
stemness-maintenance. The outcome of this study recog-
nizes the potential benefits of these seaweed polyphenols
as adjuvants for the current PC therapeutic modalities in
place, but further studies with appropriate transgenic
mouse models of spontaneous pancreatic carcinogenesis
are warranted.
Conclusions
Remarkably, we identified significant benefits of the se-
lect high-polarity antioxidant-rich seaweed polyphenols
in all-inclusive targeting of the intensified stemness in
residual PC cells. The results defined the clinical efficacy
of these polyphenols by demonstrating clone-independent
inhibition of stem cell-related molecules. Since current
conventional chemotherapy and radiotherapy are largely
ineffective in depleting CSCs, identifying novel therapeutic
strategies to selectively target CSCs is of utmost import-
ance. Since aberrant reactivation of multiple signaling
pathways is involved in the formation of PC-CSCs,
identifying drugs that could target these events could
be considered highly beneficial. Although many studies
have focused on identifying the benefits of polyphenols
from various sources to target the stem cell self-renewal
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capacity and pluripotency maintenance, these studies fo-
cused only on specific signaling events and understanding
PC-CSCs before therapy. For the first time, this study
identified three seaweed polyphenol extractions that
possess proven anti-PC potential, and the ability to target
the main signaling pathways that play critical roles in
activating and/or maintaining CSCs after first-line therapy.
In this regard, the results presented in this study are the
front-runner for understanding the potential of polyphe-
nols in therapy-orchestrated activation of PC-CSCs. How-
ever, further studies are needed to characterize these
polyphenols in the perspective of pharmacokinetics,
normal tissue cytotoxicity, in vivo bioavailability, and
drug-delivering moieties to identify potential drug deliver-
ables that could generate an archetypal shift in PC
treatment practices.
Additional files
Additional file 1: Figure S1. A Representative photomicrographs
showing the tumorosphere-forming capacity of ALDH+CD44+CD24+ PC-
CSCs. MiaPaCa-2 xenograft-derived PC-CSCs maintained ex vivo in serum
free stem-cell culture conditions showing the cellular aggregation pattern
and formation of organized tumorosphere. B Histograms obtained from
rapid and sensitive luminescent ROS-Glo™ H2O2 Assay showing significant
regulation of oxidative stress status in ALDH+CD44+CD24+ PC-CSCs
(derived from MiaPaCa-2 xenograft) exposed to SA-EA, PT-EA, or HT-EA.
Group-wise comparisons were made by ANOVA with Tukey’s post-hoc
correction using GraphPad PRISM. C Histograms of QPCR analysis showing
mRNA levels of EIF4C, OCT3/4, Nanog, LIF, and ZIC3 in ALDH+CD44+CD24+
PC-CSCs derived from xenografts of Panc-1 and MiaPaCa-2 exposed with or
without 100 μg/ml SA-EA, PT-EA, or HT-EA. Overall, seaweed polyphenols as
a standalone compound significantly reduced the transcriptional activation
of inhibited EIF4C, OCT3/4, Nanog, LIF, and ZIC3 in PC-CSCs. (PDF 1511 kb)
Additional file 2: Figure S2. Showing clinical doses of radiation (2 Gy/
day for 5 days, for a total dose of 10 Gy) significantly induced (≥2-fold
upregulation) EMT and stem cell-related transcriptome in PC-CSCs de-
rived from Panc-1, Panc-3.27, MiaPaCa-2, or BxPC-3 cells’ established xe-
nografts. Forty-three genes (ABCG2, ACAN, ADAR, ALDH1A1, ALDH2, ALPI,
APC, ASCL2, AXIN1, BGLAP, BMP3, CD4, CD8A, CDC42, CDH1, COL2A1,
COL9A1, CTNNA1, DTX1, DTX2, DVL1, FGFR1, GDF3, GJB1, GJB2, HDAC2,
HRAS, ISL1, JAG1, MSX1, MYOD1, NOTCH2, NUMB, OCLN, PPARD, S100B, SHH,
SNAI1, SNAI2, TBX2, TERT, TUBB3, TWIST1) showed consistent cell line-
independent upregulation. (PDF 839 kb)
Additional file 3: Figure S3. Showing representative microphotographs
from SOX2-stained PC TMA constructed with xenografts (established from
MiaPaCa-2) exposed to mock irradiation or fractionated irradiation, with or
without SA-EA, PT-EA, and HT-EA fractions. Pullout shows the staining
pattern (20× magnification). (PDF 2283 kb)
Additional file 4: Figure S4. Showing representative microphotographs
from PIK3R1-stained PC TMA constructed with xenografts (established from
MiaPaCa-2) exposed to mock irradiation or fractionated irradiation, with or
without SA-EA, PT-EA, and HT-EA fractions. Pullout shows the staining
pattern (20× magnification). (PDF 2998 kb)
Additional file 5: Figure S5. Showing representative microphotographs
from OCT3/4-stained PC TMA constructed with xenografts (established from
MiaPaCa-2) exposed to mock irradiation or fractionated irradiation, with or
without SA-EA, PT-EA, and HT-EA fractions. Pullout shows the staining
pattern (20× magnification). (PDF 2892 kb)
Additional file 6: Figure S6. Showing representative microphotographs
from N-Cadherin-stained PC TMA constructed with xenografts (established
from MiaPaCa-2) exposed to mock irradiation or fractionated irradiation,
with or without SA-EA, PT-EA, and HT-EA fractions. Pullout shows the
staining pattern (20× magnification). (PDF 3032 kb)
Additional file 7: Figure S7. Showing representative microphotographs
from Nanog-stained PC TMA constructed with xenografts (established from
MiaPaCa-2) exposed to mock irradiation or fractionated irradiation, with or
without SA-EA, PT-EA, and HT-EA fractions. Pullout shows the staining
pattern (20× magnification). (PDF 4861 kb)
Additional file 8: Figure S8. Showing representative microphotographs
from LIF-stained PC TMA constructed with xenografts (established from
MiaPaCa-2) exposed to mock irradiation or fractionated irradiation, with or
without SA-EA, PT-EA, and HT-EA fractions. Pullout shows the staining
pattern (20× magnification). (PDF 2688 kb)
Additional file 9: Figure S9. Showing representative microphotographs
from CD44-stained PC TMA constructed with xenografts (established from
MiaPaCa-2) exposed to mock irradiation or fractionated irradiation, with or
without SA-EA, PT-EA, and HT-EA fractions. Pullout shows the staining
pattern (20× magnification). (PDF 2910 kb)
Additional file 10: Figure S10. Showing representative
microphotographs from E-Cadherin-stained PC TMA constructed with
xenografts (established from MiaPaCa-2) exposed to mock-irradiation or
fractionated irradiation, with or without SA-EA, PT-EA, and HT-EA fractions.
Pullout shows the staining pattern (20× magnification). (PDF 2643 kb)
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